Abstract:IntroductionEssential hypertension is characterized by increased neurohumoral activation. Central Angiotensin II (AngII) increases sympathetic outflow. Our previous studies showed dysfunctional central ACE2/Ang1‐7/Mas receptor axis and increased ACE in heart failure animals with increased sympathetic activation. Mice overexpressing the human isoform of ACE2 (synhACE2) in the brain exhibit reduced sympathetic nerve activity (SNA) and a reduction in central oxidant stress. However, the mechanism by which ACE2 overexpression alters neurohumoral outflow is unknown. Our preliminary experiments showed evidence of increased central Nrf2, a redox sensitive transcription factor, in synhACE2 mice with heart failure. Nrf2 promotes antioxidant enzyme expression, but the role of this pathway in the central regulation of sympathetic outflow in response to central Ang II has not been explored.HypothesisWe hypothesized that upregulation of central ACE2 inhibits the pressor response to AngII by a Nrf2–related, antioxidant effect.MethodssynhACE2+ mice and their synhACE2‐ littermates/wild type controls (n=3–7/group) were used to evaluate blood pressure, metabolic responses, Nrf2, antioxidant enzyme expression and oxidative stress in the brain during and following 2 weeks of intracerebroventricular (icv) AngII (100 ng/kg/min) infusion. In vitro experiments were carried out using Neuro 2A cells to assess Nrf2 translocation to the nucleus in response to AngII (100 nM/24 hrs) stimulation.Resultsicv AngII induced a significant increase in mean arterial blood pressure and polydipsia (Fig.1), as well as 24‐hour norepinephrine (NE) excretion. Brain selective overexpression of synhACE2 attenuated the blood pressure (95.2 ± 4.3 mmHg vs 125.4 ± 13.1 mmHg, p<0.05), polydipsia (11.3 ± 2.5mL/day vs 27.0 ± 2.0mL/day, p<0.05) and NE in response to central Ang II (Fig.1). The Mas receptor agonist Ang1‐7 and blockade (A779) had no effects on blood pressure or drinking responses following central Ang II infusion (Fig.1). In Neuro 2A cells, nuclear Nrf2 increased in response to AngII treatment.ConclusionsThese data indicate that the hypertensive effects of icv AngII are attenuated by brain selective overexpression of synACE2—most likely mediated by the effects of ACE2 on Ang II‐AT1R signaling. These data reinforce our previous finding that brain‐selective overexpression of ACE2 attenuates sympathetic nerve activity in CHF. The cell data show that AngII is capable of translocating Nrf2 to the nucleus, which is counteracted by common antioxidants, reflecting acute Nrf2 response to oxidative stress changes.Support or Funding InformationSupported by NIH grant P01 HL62222 and a UNMC pre‐doctoral fellowshipThis abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Effect of Diminazene Aceturate, an ACE2 activator, on platelet CD40L signaling induced glial activation in rat model of hypertension

Activation of angiotensin converting enzyme 2 promotes hippocampal neurogenesis via activation of Wnt/β-catenin signaling in hypertension

Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.

Effects of Diltiazem on Platelet Activation and Cytosolic Calcium During Percutaneous Transluminal Coronary Angioplasty.

Abstract 208: Action of Multifaceted Microglia on Blood Pressure Control

Direct Pro-Inflammatory Effects of Prorenin on Microglia.

Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis

Inhibition of nitric oxide production and protein tyrosine nitration contribute to neuroprotection by a novel calmodulin antagonist, DY-9760e, in the rat microsphere embolism.

Chemical Renal Denervation-Induced Upregulation of the ACE2/Ang (1-7)/Mas Axis Attenuates Blood Pressure Elevation in Spontaneously Hypertensive Rats.

Protective Effect of Diminazene Attenuates Myocardial Infarction in Rats Via Increased Inflammation and ACE2 Activity.

The role of ACE2 in RAS axis on microglia activation in Parkinson's disease

O98 NEW APPROACHES TARGETING THE RENIN-ANGIOTENSIN SYSTEM: BRAIN ACE2 ACTIVATION FOLLOWING BRAIN AMINOPEPTIDASE A BLOCKADE BY FIRIBASTAT IN SALT-DEPENDENT HYPERTENSION

Minocycline and Pyrrolidine Dithiocarbamate Attenuate Hypertension Via Suppressing Activation of Microglia in the Hypothalamic Paraventricular Nucleus

Increased Plasma Level of Asymmetric Dimethylarginine in Hypertensive Rats Facilitates Platelet Aggregation: Role of Plasma Tissue Factor

The ACE2 Activator Diminazene Aceturate Ameliorates Colitis by Repairing the Gut-Vascular Barrier in Mice

Targeting Rap1b signaling cascades with CDNF: Mitigating platelet activation, plasma oxylipins and reperfusion injury in stroke

Diminazene aceturate or losartan ameliorates the functional, radiological and histopathological alterations in knee osteoarthritis rodent model: repurposing of the ACE2/Ang1-7/MasR cascade

Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system

Brain Selective Overexpression of ACE2 Attenuates Blood Pressure Response to Central Ang II: Potential Role of Nrf2

Overexpression of Central ACE2 (Angiotensin-Converting Enzyme 2) Attenuates the Pressor Response to Chronic Central Infusion of Ang II (angiotensin II)

Polyaspartoyl·l-arginine Inhibits Platelet Aggregation Through Stimulation of NO Release from Endothelial Cells